Agranulocytosis and hepatic toxicity with ticlopidine therapy: a case report
<p>Abstract</p> <p>Introduction</p> <p>Ticlopidine is a platelet inhibitor used to prevent thrombosis in patients with cerebrovascular or coronary artery disease. The most common side effects are mild and transitory: diarrhea, dyspepsia, nausea and rashes. More serious,...
Main Authors: | Previtera Antonino M, Pagani Rossella |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-08-01
|
Series: | Journal of Medical Case Reports |
Online Access: | http://www.jmedicalcasereports.com/content/4/1/269 |
Similar Items
-
AGRANULOCYTOSIS AND MACULOPAPULAR RASH AFTER TREATMENT WITH TICLOPIDINE – CASE REPORT
by: Janja Blatnik, et al.
Published: (2003-01-01) -
Ticlopidine-induced cholestatic hepatitis: A case report and review of the literature
by: Luigi Anastasio, et al.
Published: (2012-10-01) -
Antinuclear Antibody-Positive Ticlopidine-Induced Hepatitis
by: Sander Jo Veldhuyzen van Zanten, et al.
Published: (1996-01-01) -
Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report
by: Itathiana MªC.B. da Silva, et al. -
Neuroborreliosis in patient with aplastic anaemia secondary to therapy with ticlopidine
by: Čolović Milica, et al.
Published: (2010-01-01)